Fluorine in PDB 4yhq: Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A
Enzymatic activity of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A
All present enzymatic activity of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A:
3.4.23.16;
Protein crystallography data
The structure of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A, PDB code: 4yhq
was solved by
J.Agniswamy,
I.T.Weber,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
50.00 /
1.30
|
Space group
|
P 61
|
Cell size a, b, c (Å), α, β, γ (°)
|
60.303,
60.303,
86.141,
90.00,
90.00,
120.00
|
R / Rfree (%)
|
15.5 /
21
|
Other elements in 4yhq:
The structure of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A also contains other interesting chemical elements:
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A
(pdb code 4yhq). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A, PDB code: 4yhq:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 4yhq
Go back to
Fluorine Binding Sites List in 4yhq
Fluorine binding site 1 out
of 4 in the Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:14.3
occ:0.50
|
F39
|
A:G10201
|
0.0
|
14.3
|
0.5
|
C30
|
A:G10201
|
1.4
|
12.7
|
0.5
|
O
|
A:GLY48
|
2.1
|
15.7
|
0.5
|
F40
|
A:G10201
|
2.1
|
16.1
|
0.5
|
C29
|
A:G10201
|
2.4
|
13.1
|
0.5
|
C31
|
A:G10201
|
2.4
|
12.4
|
0.5
|
O23
|
A:G10201
|
2.8
|
11.7
|
0.5
|
C6
|
A:G10201
|
2.8
|
9.6
|
0.5
|
C24
|
A:G10201
|
2.8
|
11.5
|
0.5
|
C21
|
A:G10201
|
2.9
|
10.3
|
0.5
|
C12
|
A:G10201
|
3.1
|
12.9
|
0.5
|
O22
|
A:G10201
|
3.2
|
10.8
|
0.5
|
C35
|
A:G10201
|
3.2
|
14.4
|
0.5
|
O
|
A:HOH303
|
3.3
|
17.0
|
0.5
|
C34
|
A:G10201
|
3.3
|
14.0
|
0.5
|
C
|
A:GLY48
|
3.3
|
14.9
|
0.5
|
O
|
A:GLY48
|
3.4
|
15.4
|
0.5
|
C36
|
A:G10201
|
3.4
|
14.2
|
0.5
|
C7
|
A:G10201
|
3.4
|
12.3
|
0.5
|
O28
|
A:G10201
|
3.5
|
11.6
|
0.5
|
N20
|
A:G10201
|
3.5
|
9.4
|
0.5
|
C33
|
A:G10201
|
3.5
|
11.2
|
0.5
|
C27
|
A:G10201
|
3.6
|
12.2
|
0.5
|
C
|
A:GLY48
|
3.6
|
15.6
|
0.5
|
C37
|
A:G10201
|
3.6
|
14.1
|
0.5
|
O10
|
A:G10201
|
3.7
|
12.0
|
0.5
|
CA
|
A:GLY49
|
3.7
|
13.1
|
0.5
|
C38
|
A:G10201
|
3.7
|
11.1
|
0.5
|
C5
|
A:G10201
|
3.8
|
8.0
|
0.5
|
N
|
A:GLY49
|
3.9
|
14.6
|
0.5
|
C15
|
A:G10201
|
3.9
|
13.9
|
0.5
|
CA
|
A:GLY49
|
4.0
|
16.4
|
0.5
|
C13
|
A:G10201
|
4.0
|
9.6
|
0.5
|
S8
|
A:G10201
|
4.1
|
10.5
|
0.5
|
N11
|
A:G10201
|
4.1
|
9.9
|
0.5
|
N
|
A:GLY49
|
4.2
|
14.3
|
0.5
|
O
|
A:HOH341
|
4.3
|
33.5
|
1.0
|
C25
|
A:G10201
|
4.3
|
13.2
|
0.5
|
CA
|
A:GLY48
|
4.3
|
15.8
|
0.5
|
N
|
A:GLY48
|
4.4
|
16.7
|
0.5
|
C
|
A:GLY49
|
4.4
|
14.5
|
0.5
|
O26
|
A:G10201
|
4.4
|
13.1
|
0.5
|
C19
|
A:G10201
|
4.5
|
10.3
|
0.5
|
CA
|
A:GLY48
|
4.5
|
16.1
|
0.5
|
O
|
A:HOH375
|
4.7
|
38.5
|
1.0
|
C32
|
A:G10201
|
4.7
|
10.8
|
0.5
|
C2
|
A:G10201
|
4.7
|
10.3
|
0.5
|
C14
|
A:G10201
|
4.8
|
13.3
|
0.5
|
O
|
A:GLY49
|
4.8
|
16.1
|
0.5
|
C4
|
A:G10201
|
4.9
|
8.8
|
0.5
|
O
|
A:GLY27
|
4.9
|
12.9
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 4yhq
Go back to
Fluorine Binding Sites List in 4yhq
Fluorine binding site 2 out
of 4 in the Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:13.2
occ:0.50
|
F39
|
A:G10201
|
0.0
|
13.2
|
0.5
|
O
|
B:HOH212
|
1.0
|
28.5
|
0.5
|
C30
|
A:G10201
|
1.4
|
12.2
|
0.5
|
O
|
B:GLY48
|
2.1
|
16.4
|
0.6
|
F40
|
A:G10201
|
2.1
|
15.6
|
0.5
|
C31
|
A:G10201
|
2.4
|
11.2
|
0.5
|
C29
|
A:G10201
|
2.4
|
13.4
|
0.5
|
C6
|
A:G10201
|
2.7
|
12.2
|
0.5
|
O23
|
A:G10201
|
2.8
|
10.5
|
0.5
|
C24
|
A:G10201
|
2.8
|
10.3
|
0.5
|
C21
|
A:G10201
|
2.9
|
10.4
|
0.5
|
C12
|
A:G10201
|
3.1
|
13.0
|
0.5
|
O22
|
A:G10201
|
3.1
|
10.4
|
0.5
|
C35
|
A:G10201
|
3.3
|
12.5
|
0.5
|
C
|
B:GLY48
|
3.3
|
12.6
|
0.6
|
O
|
B:GLY48
|
3.3
|
13.6
|
0.4
|
O
|
A:HOH302
|
3.3
|
16.6
|
0.5
|
C34
|
A:G10201
|
3.3
|
12.6
|
0.5
|
C7
|
A:G10201
|
3.4
|
12.8
|
0.5
|
C36
|
A:G10201
|
3.4
|
12.2
|
0.5
|
N20
|
A:G10201
|
3.5
|
8.4
|
0.5
|
O28
|
A:G10201
|
3.5
|
10.8
|
0.5
|
O10
|
A:G10201
|
3.5
|
12.1
|
0.5
|
C33
|
A:G10201
|
3.6
|
11.1
|
0.5
|
C27
|
A:G10201
|
3.6
|
11.6
|
0.5
|
C37
|
A:G10201
|
3.6
|
12.2
|
0.5
|
C
|
B:GLY48
|
3.7
|
13.2
|
0.4
|
CA
|
B:GLY49
|
3.7
|
13.3
|
0.5
|
C5
|
A:G10201
|
3.7
|
10.1
|
0.5
|
C38
|
A:G10201
|
3.8
|
9.2
|
0.5
|
N
|
B:GLY49
|
3.9
|
14.4
|
0.5
|
C15
|
A:G10201
|
4.0
|
14.7
|
0.5
|
CA
|
B:GLY49
|
4.0
|
14.8
|
0.5
|
S8
|
A:G10201
|
4.0
|
10.8
|
0.5
|
N11
|
A:G10201
|
4.0
|
10.3
|
0.5
|
C13
|
A:G10201
|
4.0
|
11.5
|
0.5
|
N
|
B:GLY49
|
4.1
|
12.6
|
0.5
|
O
|
B:HOH238
|
4.2
|
23.6
|
0.5
|
C25
|
A:G10201
|
4.3
|
9.9
|
0.5
|
CA
|
B:GLY48
|
4.3
|
15.9
|
0.6
|
N
|
B:GLY48
|
4.3
|
15.3
|
0.6
|
C19
|
A:G10201
|
4.4
|
9.6
|
0.5
|
O26
|
A:G10201
|
4.4
|
11.5
|
0.5
|
C
|
B:GLY49
|
4.5
|
14.5
|
0.5
|
CA
|
B:GLY48
|
4.6
|
15.1
|
0.4
|
C2
|
A:G10201
|
4.7
|
11.8
|
0.5
|
C32
|
A:G10201
|
4.7
|
10.6
|
0.5
|
C14
|
A:G10201
|
4.7
|
15.2
|
0.5
|
O
|
B:HOH271
|
4.9
|
35.0
|
1.0
|
O
|
B:GLY49
|
4.9
|
16.4
|
0.5
|
C4
|
A:G10201
|
4.9
|
10.3
|
0.5
|
O
|
B:GLY27
|
5.0
|
12.7
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 4yhq
Go back to
Fluorine Binding Sites List in 4yhq
Fluorine binding site 3 out
of 4 in the Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:16.1
occ:0.50
|
F40
|
A:G10201
|
0.0
|
16.1
|
0.5
|
C30
|
A:G10201
|
1.3
|
12.7
|
0.5
|
F39
|
A:G10201
|
2.1
|
14.3
|
0.5
|
C31
|
A:G10201
|
2.2
|
12.4
|
0.5
|
O
|
A:HOH341
|
2.4
|
33.5
|
1.0
|
C29
|
A:G10201
|
2.4
|
13.1
|
0.5
|
O
|
A:GLY48
|
2.9
|
15.7
|
0.5
|
C27
|
A:G10201
|
3.0
|
12.2
|
0.5
|
O28
|
A:G10201
|
3.0
|
11.6
|
0.5
|
C24
|
A:G10201
|
3.6
|
11.5
|
0.5
|
O
|
A:HOH303
|
3.6
|
17.0
|
0.5
|
C7
|
A:G10201
|
3.7
|
12.3
|
0.5
|
O
|
A:GLY48
|
3.7
|
15.4
|
0.5
|
C
|
A:GLY48
|
3.8
|
15.6
|
0.5
|
C6
|
A:G10201
|
3.8
|
9.6
|
0.5
|
N
|
A:GLY48
|
3.8
|
16.7
|
0.5
|
C
|
A:GLY48
|
3.9
|
14.9
|
0.5
|
CA
|
A:GLY48
|
3.9
|
16.1
|
0.5
|
O23
|
A:G10201
|
4.1
|
11.7
|
0.5
|
CA
|
A:GLY48
|
4.2
|
15.8
|
0.5
|
C35
|
A:G10201
|
4.2
|
14.4
|
0.5
|
NH2
|
B:ARG8
|
4.2
|
15.6
|
0.2
|
C34
|
A:G10201
|
4.3
|
14.0
|
0.5
|
N
|
A:GLY48
|
4.3
|
17.5
|
0.5
|
O26
|
A:G10201
|
4.3
|
13.1
|
0.5
|
N
|
A:GLY49
|
4.4
|
14.6
|
0.5
|
O
|
A:HOH375
|
4.5
|
38.5
|
1.0
|
OD2
|
A:ASP29
|
4.6
|
23.2
|
1.0
|
C25
|
A:G10201
|
4.6
|
13.2
|
0.5
|
C21
|
A:G10201
|
4.7
|
10.3
|
0.5
|
C33
|
A:G10201
|
4.9
|
11.2
|
0.5
|
C36
|
A:G10201
|
4.9
|
14.2
|
0.5
|
CA
|
A:GLY49
|
4.9
|
13.1
|
0.5
|
C
|
A:VAL47
|
4.9
|
17.3
|
0.5
|
C2
|
A:G10201
|
5.0
|
10.3
|
0.5
|
|
Fluorine binding site 4 out
of 4 in 4yhq
Go back to
Fluorine Binding Sites List in 4yhq
Fluorine binding site 4 out
of 4 in the Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Multidrug Resistant Clinical Isolate PR20 with Grl-5010A within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F201
b:15.6
occ:0.50
|
F40
|
A:G10201
|
0.0
|
15.6
|
0.5
|
C30
|
A:G10201
|
1.3
|
12.2
|
0.5
|
O
|
B:HOH212
|
1.4
|
28.5
|
0.5
|
F39
|
A:G10201
|
2.1
|
13.2
|
0.5
|
C31
|
A:G10201
|
2.3
|
11.2
|
0.5
|
C29
|
A:G10201
|
2.3
|
13.4
|
0.5
|
O
|
B:HOH238
|
2.3
|
23.6
|
0.5
|
O
|
B:GLY48
|
2.9
|
16.4
|
0.6
|
C27
|
A:G10201
|
3.0
|
11.6
|
0.5
|
O28
|
A:G10201
|
3.0
|
10.8
|
0.5
|
O
|
A:HOH302
|
3.6
|
16.6
|
0.5
|
C24
|
A:G10201
|
3.6
|
10.3
|
0.5
|
C7
|
A:G10201
|
3.7
|
12.8
|
0.5
|
O
|
B:GLY48
|
3.7
|
13.6
|
0.4
|
C6
|
A:G10201
|
3.8
|
12.2
|
0.5
|
N
|
B:GLY48
|
3.9
|
15.3
|
0.6
|
C
|
B:GLY48
|
3.9
|
13.2
|
0.4
|
C
|
B:GLY48
|
3.9
|
12.6
|
0.6
|
O23
|
A:G10201
|
4.1
|
10.5
|
0.5
|
CA
|
B:GLY48
|
4.1
|
15.1
|
0.4
|
C35
|
A:G10201
|
4.2
|
12.5
|
0.5
|
C34
|
A:G10201
|
4.2
|
12.6
|
0.5
|
N
|
B:GLY48
|
4.3
|
14.9
|
0.4
|
CA
|
B:GLY48
|
4.3
|
15.9
|
0.6
|
O26
|
A:G10201
|
4.3
|
11.5
|
0.5
|
NH1
|
A:ARG8
|
4.5
|
29.8
|
0.5
|
OD2
|
B:ASP29
|
4.5
|
23.1
|
1.0
|
N
|
B:GLY49
|
4.6
|
14.4
|
0.5
|
O
|
B:HOH271
|
4.6
|
35.0
|
1.0
|
C25
|
A:G10201
|
4.6
|
9.9
|
0.5
|
C21
|
A:G10201
|
4.7
|
10.4
|
0.5
|
C36
|
A:G10201
|
4.9
|
12.2
|
0.5
|
C33
|
A:G10201
|
4.9
|
11.1
|
0.5
|
C2
|
A:G10201
|
4.9
|
11.8
|
0.5
|
CB
|
B:VAL47
|
5.0
|
15.3
|
0.5
|
C
|
B:VAL47
|
5.0
|
14.0
|
0.5
|
|
Reference:
J.Agniswamy,
J.M.Louis,
C.H.Shen,
S.Yashchuk,
A.K.Ghosh,
I.T.Weber.
Substituted Bis-Thf Protease Inhibitors with Improved Potency Against Highly Resistant Mature Hiv-1 Protease PR20. J.Med.Chem. V. 58 5088 2015.
ISSN: ISSN 0022-2623
PubMed: 26010498
DOI: 10.1021/ACS.JMEDCHEM.5B00474
Page generated: Thu Aug 1 06:59:02 2024
|